Q32 Bio (QTTB) EBT (2017 - 2026)
Q32 Bio's (QTTB) quarterly EBT came in at -$16.1 million in Q1 2026, down 45.83% year-on-year from -$29.7 million in Q1 2025, and down 127.87% quarter-over-quarter from $57.7 million in Q4 2025.
Q32 Bio (QTTB) EBT (2017 - 2026) Analysis & Trends
Q32 Bio's EBT history runs 10 years deep, the most recent figure standing at -$16.1 million for Q1 2026.
- On a quarterly basis, EBT fell 45.83% year-over-year to -$16.1 million in Q1 2026; TTM through Mar 2026 was $24.8 million, a 142.46% increase from a year earlier, with the FY2025 full-year figure at $29.8 million, up 164.71% from the prior year.
- EBT retreated to -$16.1 million in Q1 2026 per QTTB's latest filing, from $57.7 million in the prior quarter.
- Across five years, EBT topped out at $93.7 million in Q1 2022 and bottomed at -$33.0 million in Q4 2022.
- The 5-year median for EBT is -$14.0 million (2023), against an average of -$5.0 million.
- Across the five-year window, EBT soared 8829.08% in 2022 and tumbled 1015.44% in 2025, its largest moves.
- Year by year, EBT stood at -$33.0 million in 2022, then rose by 18.84% to -$26.8 million in 2023, then jumped by 47.16% to -$14.2 million in 2024, then jumped by 507.47% to $57.7 million in 2025, then plunged by 127.87% to -$16.1 million in 2026.
- Per Business Quant, the three latest QTTB EBT figures stand at -$16.1 million (Q1 2026), $57.7 million (Q4 2025), and -$7.4 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Q32 Bio | 225.00 Mn | 174.25 Mn | - | -16.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.09 Mn |
| Dec 31, 2025 | 57.73 Mn |
| Sep 30, 2025 | -7.39 Mn |
| Jun 30, 2025 | -9.49 Mn |
| Mar 31, 2025 | -11.03 Mn |
| Dec 31, 2024 | -14.17 Mn |
| Sep 30, 2024 | -17.60 Mn |
| Jun 30, 2024 | -15.53 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | -26.81 Mn |
| Sep 30, 2023 | -13.97 Mn |
| Jun 30, 2023 | -5.81 Mn |
| Mar 31, 2023 | -6.84 Mn |
| Dec 31, 2022 | -33.04 Mn |
| Sep 30, 2022 | -31.59 Mn |
| Jun 30, 2022 | -27.83 Mn |
| Mar 31, 2022 | 93.66 Mn |
| Dec 31, 2021 | -33.58 Mn |
| Sep 30, 2021 | -30.61 Mn |
| Jun 30, 2021 | -30.50 Mn |